Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03084406 · ClinicalTrials.gov registry record · NA
Efficacy of Centervention-ATOD: An Implementation Tool for Dissemination of Evidence-based Programs for Substance Abuse
A NA study, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- NA
- Development phase
- 327
- Enrollment target
NCT03084406: Completed NA study, sponsored by 3-C Institute for Social Development.
NCT03084406 is a NA study that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 327 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03084406, a NA study, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 327 participants
- Enrollment target
Study Summary
The pilot test of Centervention-ATOD, a customizable suite of online tools specifically designed to support quality implementation and sustainability of any ATOD-EBP within real-world service settings, will evaluate whether the product awards additive benefits in provider implementation proficiency and efficacy, quality of implementation delivery, and EBP (i.e., Free Talk or CHOICE) outcomes compared to traditional implementation methods. Additionally, a cost-effectiveness study will be conducted to assess whether the implementation support strategy (i.e., Centervention-ATOD) is more cost-effective than traditional implementation methods.
Primary Outcome
Providers will take an EBP knowledge and MI skills test of 25 questions from a bank of questions produced by the EBP developer.
Interventions
- OTHER Centervention-ATOD (CV-ATOD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2017-12-22 |
| Phase | NA |
What the finished NCT03084406 record still lists
NCT03084406 is an interventional study that assigns participants to a tested intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which Centervention-ATOD (CV-ATOD) is the first listed.
NCT03084406 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03084406 about?
NCT03084406 is a clinical study titled "Efficacy of Centervention-ATOD: An Implementation Tool for Dissemination of Evidence-based Programs for Substance Abuse". The pilot test of Centervention-ATOD, a customizable suite of online tools specifically designed to support quality implementation and sustainability of any ATOD-EBP within real-world service settings, will evaluate whether the product awards additive benefits in provider implementation proficiency ...
What is the current status of trial NCT03084406?
This trial is currently completed. It is a NA study. The enrollment target is 327 participants. The study started on 2017-02-13. Estimated completion is 2017-12-22.
What interventions are being tested in trial NCT03084406?
The interventions under investigation include: Centervention-ATOD (CV-ATOD) (OTHER).
Who is sponsoring clinical trial NCT03084406?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03084406's enrollment target sits among peer trials
327 309th of 2000 higher than 1,691 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT06370182 · 327 participants · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI